 | • レポートコード：MRC2312MG09780 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、64ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のハイパー個別化医療市場規模と予測を収録しています。・世界のハイパー個別化医療市場：売上、2018年-2023年、2024年-2029年 ・世界のハイパー個別化医療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のハイパー個別化医療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ハイパー個別化医療診断薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ハイパー個別化医療のグローバル主要企業は、Danaher Corporation、 lllumina, Inc.、 Decode Genetics, Inc.、 Dako A/SASURAGEN,INC.、 GE Healthcare、 QIAGEN、 Exagen lnc.、 Exact Sciences Corporation、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ハイパー個別化医療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のハイパー個別化医療市場：タイプ別、2018年-2023年、2024年-2029年 世界のハイパー個別化医療市場：タイプ別市場シェア、2022年 ・ハイパー個別化医療診断薬、ハイパー個別化医療治療薬、ハイパー・パーソナライズド・メディカル・ケア、ハイパー・パーソナライズド・ニュートリション&ウェルネス 世界のハイパー個別化医療市場：用途別、2018年-2023年、2024年-2029年 世界のハイパー個別化医療市場：用途別市場シェア、2022年 ・病院、診断センター、研究&学術機関、その他 世界のハイパー個別化医療市場：地域・国別、2018年-2023年、2024年-2029年 世界のハイパー個別化医療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるハイパー個別化医療のグローバル売上、2018年-2023年 ・主要企業におけるハイパー個別化医療のグローバル売上シェア、2022年 ・主要企業におけるハイパー個別化医療のグローバル販売量、2018年-2023年 ・主要企業におけるハイパー個別化医療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Danaher Corporation、 lllumina, Inc.、 Decode Genetics, Inc.、 Dako A/SASURAGEN,INC.、 GE Healthcare、 QIAGEN、 Exagen lnc.、 Exact Sciences Corporation、 Abbott ************************************************************* ・調査・分析レポートの概要 ハイパー個別化医療市場の定義 市場セグメント 世界のハイパー個別化医療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のハイパー個別化医療市場規模 世界のハイパー個別化医療市場規模：2022年 VS 2029年 世界のハイパー個別化医療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのハイパー個別化医療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のハイパー個別化医療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ハイパー個別化医療診断薬、ハイパー個別化医療治療薬、ハイパー・パーソナライズド・メディカル・ケア、ハイパー・パーソナライズド・ニュートリション&ウェルネス ハイパー個別化医療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診断センター、研究&学術機関、その他 ハイパー個別化医療の用途別グローバル売上・予測 ・地域別市場分析 地域別ハイパー個別化医療市場規模 2022年と2029年 地域別ハイパー個別化医療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Danaher Corporation、 lllumina, Inc.、 Decode Genetics, Inc.、 Dako A/SASURAGEN,INC.、 GE Healthcare、 QIAGEN、 Exagen lnc.、 Exact Sciences Corporation、 Abbott ... |
This research report provides a comprehensive analysis of the Hyper Personalized Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hyper Personalized Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hyper Personalized Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Hyper Personalized Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hyper Personalized Medicine market presents opportunities for various stakeholders, including Hospitals, Diagnostic Centers. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hyper Personalized Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Hyper Personalized Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Hyper Personalized Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hyper Personalized Medicine market.
Market Overview: The report provides a comprehensive overview of the Hyper Personalized Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hyper Personalized Medicine Diagnostics, Hyper Personalized Medicine Therapeutics), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hyper Personalized Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hyper Personalized Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hyper Personalized Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hyper Personalized Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hyper Personalized Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hyper Personalized Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hyper Personalized Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hyper Personalized Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hyper Personalized Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Hyper Personalized Medicine Diagnostics
Hyper Personalized Medicine Therapeutics
Hyper Personalized Medical Care
Hyper Personalized Nutrition and Wellness
Market segment by Application
Hospitals
Diagnostic Centers
Research and Academic Institutes
Others
Global Hyper Personalized Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Danaher Corporation
lllumina, Inc.
Decode Genetics, Inc.
Dako A/SASURAGEN,INC.
GE Healthcare
QIAGEN
Exagen lnc.
Exact Sciences Corporation
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyper Personalized Medicine, market overview.
Chapter 2: Global Hyper Personalized Medicine market size in revenue.
Chapter 3: Detailed analysis of Hyper Personalized Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyper Personalized Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hyper Personalized Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyper Personalized Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyper Personalized Medicine Overall Market Size
2.1 Global Hyper Personalized Medicine Market Size: 2022 VS 2029
2.2 Global Hyper Personalized Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hyper Personalized Medicine Players in Global Market
3.2 Top Global Hyper Personalized Medicine Companies Ranked by Revenue
3.3 Global Hyper Personalized Medicine Revenue by Companies
3.4 Top 3 and Top 5 Hyper Personalized Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hyper Personalized Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hyper Personalized Medicine Players in Global Market
3.6.1 List of Global Tier 1 Hyper Personalized Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Hyper Personalized Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Hyper Personalized Medicine Market Size Markets, 2022 & 2029
4.1.2 Hyper Personalized Medicine Diagnostics
4.1.3 Hyper Personalized Medicine Therapeutics
4.1.4 Hyper Personalized Medical Care
4.1.5 Hyper Personalized Nutrition and Wellness
4.2 By Type – Global Hyper Personalized Medicine Revenue & Forecasts
4.2.1 By Type – Global Hyper Personalized Medicine Revenue, 2018-2023
4.2.2 By Type – Global Hyper Personalized Medicine Revenue, 2024-2029
4.2.3 By Type – Global Hyper Personalized Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hyper Personalized Medicine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Research and Academic Institutes
5.1.5 Others
5.2 By Application – Global Hyper Personalized Medicine Revenue & Forecasts
5.2.1 By Application – Global Hyper Personalized Medicine Revenue, 2018-2023
5.2.2 By Application – Global Hyper Personalized Medicine Revenue, 2024-2029
5.2.3 By Application – Global Hyper Personalized Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Hyper Personalized Medicine Market Size, 2022 & 2029
6.2 By Region – Global Hyper Personalized Medicine Revenue & Forecasts
6.2.1 By Region – Global Hyper Personalized Medicine Revenue, 2018-2023
6.2.2 By Region – Global Hyper Personalized Medicine Revenue, 2024-2029
6.2.3 By Region – Global Hyper Personalized Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Hyper Personalized Medicine Revenue, 2018-2029
6.3.2 US Hyper Personalized Medicine Market Size, 2018-2029
6.3.3 Canada Hyper Personalized Medicine Market Size, 2018-2029
6.3.4 Mexico Hyper Personalized Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Hyper Personalized Medicine Revenue, 2018-2029
6.4.2 Germany Hyper Personalized Medicine Market Size, 2018-2029
6.4.3 France Hyper Personalized Medicine Market Size, 2018-2029
6.4.4 U.K. Hyper Personalized Medicine Market Size, 2018-2029
6.4.5 Italy Hyper Personalized Medicine Market Size, 2018-2029
6.4.6 Russia Hyper Personalized Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Hyper Personalized Medicine Market Size, 2018-2029
6.4.8 Benelux Hyper Personalized Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Hyper Personalized Medicine Revenue, 2018-2029
6.5.2 China Hyper Personalized Medicine Market Size, 2018-2029
6.5.3 Japan Hyper Personalized Medicine Market Size, 2018-2029
6.5.4 South Korea Hyper Personalized Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Hyper Personalized Medicine Market Size, 2018-2029
6.5.6 India Hyper Personalized Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Hyper Personalized Medicine Revenue, 2018-2029
6.6.2 Brazil Hyper Personalized Medicine Market Size, 2018-2029
6.6.3 Argentina Hyper Personalized Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Hyper Personalized Medicine Revenue, 2018-2029
6.7.2 Turkey Hyper Personalized Medicine Market Size, 2018-2029
6.7.3 Israel Hyper Personalized Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Hyper Personalized Medicine Market Size, 2018-2029
6.7.5 UAE Hyper Personalized Medicine Market Size, 2018-2029
7 Hyper Personalized Medicine Companies Profiles
7.1 Danaher Corporation
7.1.1 Danaher Corporation Company Summary
7.1.2 Danaher Corporation Business Overview
7.1.3 Danaher Corporation Hyper Personalized Medicine Major Product Offerings
7.1.4 Danaher Corporation Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.1.5 Danaher Corporation Key News & Latest Developments
7.2 lllumina, Inc.
7.2.1 lllumina, Inc. Company Summary
7.2.2 lllumina, Inc. Business Overview
7.2.3 lllumina, Inc. Hyper Personalized Medicine Major Product Offerings
7.2.4 lllumina, Inc. Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.2.5 lllumina, Inc. Key News & Latest Developments
7.3 Decode Genetics, Inc.
7.3.1 Decode Genetics, Inc. Company Summary
7.3.2 Decode Genetics, Inc. Business Overview
7.3.3 Decode Genetics, Inc. Hyper Personalized Medicine Major Product Offerings
7.3.4 Decode Genetics, Inc. Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.3.5 Decode Genetics, Inc. Key News & Latest Developments
7.4 Dako A/SASURAGEN,INC.
7.4.1 Dako A/SASURAGEN,INC. Company Summary
7.4.2 Dako A/SASURAGEN,INC. Business Overview
7.4.3 Dako A/SASURAGEN,INC. Hyper Personalized Medicine Major Product Offerings
7.4.4 Dako A/SASURAGEN,INC. Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.4.5 Dako A/SASURAGEN,INC. Key News & Latest Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Company Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Hyper Personalized Medicine Major Product Offerings
7.5.4 GE Healthcare Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.5.5 GE Healthcare Key News & Latest Developments
7.6 QIAGEN
7.6.1 QIAGEN Company Summary
7.6.2 QIAGEN Business Overview
7.6.3 QIAGEN Hyper Personalized Medicine Major Product Offerings
7.6.4 QIAGEN Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.6.5 QIAGEN Key News & Latest Developments
7.7 Exagen lnc.
7.7.1 Exagen lnc. Company Summary
7.7.2 Exagen lnc. Business Overview
7.7.3 Exagen lnc. Hyper Personalized Medicine Major Product Offerings
7.7.4 Exagen lnc. Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.7.5 Exagen lnc. Key News & Latest Developments
7.8 Exact Sciences Corporation
7.8.1 Exact Sciences Corporation Company Summary
7.8.2 Exact Sciences Corporation Business Overview
7.8.3 Exact Sciences Corporation Hyper Personalized Medicine Major Product Offerings
7.8.4 Exact Sciences Corporation Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.8.5 Exact Sciences Corporation Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Hyper Personalized Medicine Major Product Offerings
7.9.4 Abbott Hyper Personalized Medicine Revenue in Global Market (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer